InvestorsHub Logo

Pharmacydude

07/23/21 11:38 PM

#347913 RE: sstyles #347911

Sstyles
Data will have to be very solid because every other oral medication for Covid has had their data ripped apart and found to be unreliable. Hydroxychloroquin, colchicine, methotrexate, and a major fraud with ivermectin have everyone very sceptical and the reason I don’t think they will reveal anything until ESC and publication in a peer reviewed journal.
4,000 pts, placebo controlled double blind RCT by academics should be good especially for a CVD drug with minimal side effects and amazing CVD results.
I like our chances.

sts66

07/24/21 5:18 PM

#347952 RE: sstyles #347911

If that trial is a success we'll hear Nissen et al claiming the results need to be duplicated in a different population because the state of Argentina's health care system is poor compared to more developed countries (read rich ones).